{"schema_version":"secwatch.filing_event.v1","accession":"0001171843-22-003330","form_type":"8-K","ticker":"JYNT","cik":"0001612630","company_name":"JOINT Corp","filed_at":"2022-05-05T23:59:59+00:00","discovered_at":"2026-05-14T18:04:01.484455+00:00","generated_at":"2026-06-25T23:43:57.993323+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"The Joint Corp. Q1 revenue $22.4M (+28% YoY); net loss $206K; adj. EBITDA $1.8M; updates guidance","bullets":["Revenue $22.4M, up 28% YoY; system-wide sales $98.8M (+27%); comp sales +15%.","Net loss $206K ($0.01/sh) vs net income $2.3M ($0.16 diluted) in Q1 2021.","Adjusted EBITDA $1.8M, down from $3.5M; operating loss $176K vs profit $2.0M.","Opened 31 clinics (27 franchised, 4 greenfield) – record Q1; total clinics 736.","Guidance updated: FY rev $98-102M; adj. EBITDA $12-14M; 110-130 franchised openings."],"urls":{"canonical":"https://secwatch.observer/filing/0001171843-22-003330","json":"https://secwatch.observer/filing/0001171843-22-003330.json","markdown":"https://secwatch.observer/filing/0001171843-22-003330.md","text":"https://secwatch.observer/filing/0001171843-22-003330.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1612630/000117184322003330/0001171843-22-003330-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1612630/000117184322003330/f8k_050522.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-25T23:43:57.993323+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}